Literature DB >> 2905244

Antisecretory drugs. Safe and effective?

M J Langman1.   

Abstract

Surveillance of takers of the antisecretory drug cimetidine has failed to reveal any disturbing trends. This pattern is reassuring but the difficulties of detecting drug-induced disease mimicking ordinary community complaints deserve emphasis. Experience since the surveillance study began has not revealed any disturbing trends. Observed mortality rates have fallen to match population expectation, both for ordinary disease and for cancer. The pattern is generally reassuring and suggests that significant drug-induced disease is not being missed. Nevertheless the ability of this or any other surveillance study to detect drug-induced illness mimicking ordinary disease is likely to be low.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2905244     DOI: 10.2165/00003495-198800353-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  2 in total

1.  Postmarketing surveillance of the safety of cimetidine: mortality during second, third, and fourth years of follow up.

Authors:  D G Colin-Jones; M J Langman; D H Lawson; M P Vessey
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-19

2.  Postmarketing surveillance of the safety of cimetidine: 12 month mortality report.

Authors:  D G Colin-Jones; M J Langman; D H Lawson; M P Vessey
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.